Tag

Novo Nordisk

Mads Krogsgaard Thomsen

Novo Nordisk’s Esperoct approved in the EU

June 24, 2019

The European Commission has granted …

Presentation

New clinical trials results from Novo Nordisk

June 12, 2019

Findings presented from two phase …

Lars Fruergaard Joergensen

Novo Nordisk’s operating profit increased by 14% in Q1 2019

May 7, 2019

The company’s sales increased by …

Mads Krogsgaard Thomsen

Novo Nordisk and Gilead Sciences initiate collaboration

April 23, 2019

The two companies intend to …

Kalundborg

Novo Nordisk invests DKK 650 million in its Kalundborg site

April 5, 2019

The company will upgrade and …

Mads Krogsgaard Thomsen

Novo Nordisk has submitted two new NDAs to the FDA

March 26, 2019

The company announced the submission …

Mads Krogsgaard Thomsen

Novo Nordisk demonstrate positive results with Semaglutide

February 1, 2018

The results from the SUSTAIN …

Novo Nordisk headquarters

Novo Nordisk does not intend to make a revised proposal for Ablynx

January 31, 2018

The company notes the announcement …

Edwin Moses

Sanofi acquires Ablynx for 3.9 billion EUR

January 29, 2018

Sanofi will acquire the Belgian …

Lars Fruergaard Joergensen

Ablynx rejects Novo Nordisk’s $3.1 billion bid

January 25, 2018

The Danish pharma giant’s proposal …

Doug Langa

Novo Nordisk announces conclusion of investigation of marketing practices

September 11, 2017

Novo Nordisk has reached a …

novo-nordisk-headquarters

Novo’s Victoza has been approved in the EU

August 11, 2017

The European Commission has approved …

Novo Nordisk Headquarters

NNIT, Novo Nordisk renew agreement

May 8, 2017

NNIT has signed an extension …

Mads Krogsgaard Thomsen

“We have to embrace the new era of diabetes care”

March 8, 2017

Mads Krogsgaard Thomsen, Executive Vice …

novo-nordisk-oxford-center

Novo Nordisk invests in new research center

January 31, 2017

University of Oxford and Novo …

glooko-app

Novo Nordisk and Glooko partner

January 30, 2017

Novo Nordisk and Glooko announces …

1
2
3
···
6